Patient materials for Shire’s ADHD drug Intuniv presented unsubstantiated effectiveness and superiority claims and downplayed important risk info, said the FDA’s Division of Drug Marketing, ...

The FDA's approval of Intuniv brings to four the number of drugs for ADHD currently marketed by Shire. (The other three are Adderall XR, Vyvanse and the Daytrana patch.) There are about 11 drugs on ...

Intuniv is available as 1mg, 2mg, 3mg, and 4mg extended-release tablets The Food and Drug Administration (FDA) has approved a new update to the Intuniv (guanfacine; Shire) labeling regarding ...

Days after announcing plans to sue Teva Pharmaceutical Industries over patent infringement of Intuniv, Shire has been informed that another company is hoping to launch its generic version of the ...

NEW YORK (AP) -- Irish drugmaker Shire PLC said Thursday it settled a lawsuit over the patents on its attention deficit hyperactivity drug Intuniv, and will allow another company to make a generic ...